We are live on ! Find out more
DVC

Deer VII & Co Portfolio holdings

AUM $317M
1-Year Est. Return 30.89%
This Fund
S&P 500
This Quarter Est. Return
+37.2%
1 Year Est. Return
+30.89%
3 Year Est. Return
+241.3%
5 Year Est. Return
+1,036.06%
10 Year Est. Return
AUM
$83.7M
AUM Growth
+$56.9M
Cap. Flow
+$46.7M
Cap. Flow %
55.77%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
DOCU
DocuSign
DOCU
+$46.7M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 54.07%
2 Healthcare 45.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOCU
1
DocuSign
DOCU
$10.7B
$45.3M 54.07%
+925,000
New +$46.7M
ALNA
2
DELISTED
Allena Pharmaceuticals
ALNA
$29.5M 35.22%
2,263,365
VSTM icon
3
Verastem
VSTM
$547M
$8.19M 9.78%
99,197
TARA icon
4
Protara Therapeutics
TARA
$221M
$772K 0.92%
7,878

Similar funds

Deer VII & Co's Q2 2018 Portfolio in Review

As of Q2 2018, Deer VII & Co held 4 positions worth $83.7M, up 213% from $26.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Deer VII & Co deployed $46.7M of net new capital in Q2 2018, opening 1 new position. Its largest new stake was DocuSign: 925,000 shares worth $45.3M.

By sector, the portfolio is most concentrated in Technology at 54% of assets, followed by Healthcare.

  • Deer VII & Co's largest Q2 2018 buy was DocuSign: 925,000 shares worth $45.3M.
  • Deer VII & Co's ten largest holdings make up 100% of its $83.7M portfolio in Q2 2018.
  • Deer VII & Co opened 1 new position and closed 0 in Q2 2018.
  • Deer VII & Co's portfolio value rose 213% quarter-over-quarter to $83.7M.

Based on Deer VII & Co's 13F filing for Q2 2018, filed 14 Aug 2018.